001     272955
005     20250715111246.0
024 7 _ |2 doi
|a 10.5281/ZENODO.7904832
024 7 _ |2 doi
|a 10.5281/zenodo.7904832
024 7 _ |2 doi
|a 10.5281/zenodo.7904831
037 _ _ |a DZNE-2024-01334
100 1 _ |0 P:(DE-2719)9001970
|a Leonard, Hampton
|b 0
245 _ _ |a Dataset: Global Parkinson's Genetics Program Data Release 5, v1
260 _ _ |b Zenodo
|c 2023
336 7 _ |2 BibTeX
|a MISC
336 7 _ |0 PUB:(DE-HGF)32
|2 PUB:(DE-HGF)
|a Dataset
|b dataset
|m dataset
|s 1732528429_17378
336 7 _ |0 26
|2 EndNote
|a Chart or Table
336 7 _ |2 DataCite
|a Dataset
336 7 _ |2 ORCID
|a DATA_SET
336 7 _ |2 DINI
|a ResearchData
520 _ _ |a In May 2023, GP2 announced the fifth data release on the Terra platform in collaboration with AMP® PD. This release includes 7,462 additional new complex disease participants and 487 new monogenic disease participants, adding to the previous releases from the Complex and Monogenic Networks. The complex disease data (genotypes) now consists of a total of 24,935 genotyped participants (12,728 PD cases, 10,533 Controls, and 1,674 ‘Other’ phenotypes). The monogenic disease data (whole genome sequences) now consists of a total of 722 sequenced participants. Please see the accompanying blog for further description of this release. To obtain data access, please see https://amp-pd.org/researchers/data-use-agreement . For any publications using data from this release, please reference the DOI number and the following statement: ' Data (DOI 10.5281/zenodo.7904832, release 5) used in the preparation of this article were obtained from the Global Parkinson’s Genetics Program (GP2).'
536 _ _ |0 G:(DE-HGF)POF4-354
|a 354 - Disease Prevention and Healthy Aging (POF4-354)
|c POF4-354
|f POF IV
|x 0
588 _ _ |a Dataset connected to DataCite
700 1 _ |a Nalls, Mike
|b 1
700 1 _ |a Vitale, Dan
|b 2
700 1 _ |a Koretsky, Mathew
|b 3
700 1 _ |a Levine, Kristin
|b 4
700 1 _ |a Makarious, Mary
|b 5
700 1 _ |0 P:(DE-2719)9001362
|a Fang, Zih-Hua
|b 6
|e Last author
773 _ _ |a 10.5281/zenodo.7904832
787 0 _ |0 DZNE-2024-01333
|a Bandres-Ciga, Sara et.al.
|d New York, NY : Wiley, 2024
|i RelatedTo
|t NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations.
909 C O |o oai:pub.dzne.de:272955
|p VDB
910 1 _ |0 I:(DE-588)1065079516
|6 P:(DE-2719)9001362
|a Deutsches Zentrum für Neurodegenerative Erkrankungen
|b 6
|k DZNE
913 1 _ |0 G:(DE-HGF)POF4-354
|1 G:(DE-HGF)POF4-350
|2 G:(DE-HGF)POF4-300
|3 G:(DE-HGF)POF4
|4 G:(DE-HGF)POF
|a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|v Disease Prevention and Healthy Aging
|x 0
914 1 _ |y 2024
920 1 _ |0 I:(DE-2719)1210002
|k AG Heutink
|l Genome Biology of Neurodegenerative Diseases
|x 0
980 _ _ |a dataset
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1210002
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21